Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications ...

The AAV vector manufacturing market is growing by leaps and bounds as the demand for gene and cell therapies is progressing rapidly. VANCOUVER, BRITISH COLUMBIA, CANADA, January 16, 2025 ...

However, scaling up AAV manufacturing to obtain sufficient yields to meet the demands of new research initiatives and clinical applications is challenging using traditional approaches. Download this ...

Andelyn currently offers both adherent and suspension mode manufacturing of research grade AAV vectors up to 200 L in scale, to support preclinical studies including viral vector process and ...

In addition to AGTC, Solid Biosciences has adopted an HSV production system for its AAV production. Good help appears to be on the way. For more information, visit Vigene Biosciences.

Viralgen and two labs based in the Broad Institute of MIT (Massachusetts Institute of Technology) and Harvard University have ...

ProBioGen today announces the expansion of both protein and virus manufacturing at its Berlin headquarters. This includes the commissioning of an additional 1000L-scale GMP production line for ...

Roche has exercised its option to license a novel capsid from Dyno Therapeutics for use in a gene therapy program for an ...

Common measurements for modified adeno-associated viruses (AAVs), a gene therapy delivery method, showed substantial ...

Adeno-associated viral (AAV) vectors in particular have high transduction rates and reduced toxicity concerns compared to other viral vectors. However, these delivery vehicles present some application ...

Scientists looked at multiple techniques used to measure the modified viruses deployed in some gene therapy research and treatments. One technique, known as SEC-MALS, was the most precise and accurate ...